Kruppel-like Factor and Maturation of hESC/hiPSC Derived Cardiomyoctyes
Kruppel-like Factor and Maturation of hESC/hiPSC Derived Cardiomyoctyes
批准号:
8386169
负责人:
MARK MERCOLA
金额:
$29.25万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-12 至 2014-06-30
关键词:
AccountingAction PotentialsAdultApplied ResearchBasic ScienceBindingBiological AssayCalciumCardiacCardiac MyocytesCell membraneCellsCherry - dietaryClinicalComputer softwareConditioned Culture MediaDataDevelopmentEpitopesEvaluationExhibitsExploratory/Developmental GrantFamilyGene ExpressionGene ProteinsGene TargetingGenerationsGovernmentHeartHuman GenomeIn VitroIndividualIon ChannelIon PumpsLeadLibrariesMass Spectrum AnalysisMechanicsMediator of activation proteinMedical ResearchMethodsMetricMicroarray AnalysisModelingMolecular GeneticsMolecular Mechanisms of ActionMolecular ProfilingMuscle CellsMyocardialNatural regenerationNatureNeonatalParacrine CommunicationPersonsPhysiologicalPhysiologyPredictive ValuePropertyProteinsProtocols documentationPumpRattusRegulationRepressionResearchRiskScreening procedureSignal TransductionSmall Interfering RNASourceStagingStem cellsStructureTechnologyTestingTimeTranscriptTranslatingTransplantationValidationVascular Endothelial CellVentricularbasecardiogenesisclinical applicationdrug candidatedrug discoverydrug sensitivityelectrical propertyenhancing factorfetalhuman embryonic stem cellimprovedin vivoinstrumentationion channel blockermembernext generationresponsetranscription factorvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This R21 proposal is to determine if Kr¿ppel-like factors (KLFs) promote functional maturation of stem cell- derived cardiomyocytes, and to establish the physiological and molecular genetic basis for the maturational effects. An important impediment to realizing the promise of hESC and hiPSC-derived cardiomyocytes for drug discovery, research and myocardial regeneration is that stem cell-derived cardiomyocytes exhibit electrical and mechanical properties of fetal, rather than adult, cells. Critically, immatue cardiomyocytes do not generate the force of mature myocytes, and their electrical properties are potentially arrhythmogenic in a transplant setting. Moreover, immature ion channel and physiological properties diminish the predictive value of in vitro analyses such as for assessing adverse cardiac effects of drug candidates. Although efficient protocols are now used to derive cardiomyocytes from stem cells, even the best yield immature, fetal-like cells since very little is
known about the signals that direct maturation. Data are presented showing the development of instrumentation and software for high throughput assessment of electrophysiological maturation. Using this technology, we provide preliminary evidence that KLFs can promote electrical and ion channel profile maturation of hESC-derived and neonatal rat ventricular cardiomyocytes. The specific aims of this proposal are to: 1) define the KLF-induced maturation by functional expression of ion channels and pumps, drug sensitivity profiling, action potential and calcium handling metrics, contractile apparatus structure, and force generation; and 2) establish the molecular genetic basis for the physiological effects, in part by determining the binding partners and gene targets of KLFs by mass spectroscopic and next generation ChIPSeq analyses. The identification of signals that promote cardiomyocyte maturation should lead to improved methods for deriving functional cardiomyocytes that will be enabling for many stem cell applications in basic and applied research. Moreover, the ability to direct exogenous or endogenous stem cell sources will be essential to achieve functional regeneration of the heart.
PUBLIC HEALTH RELEVANCE: This project is to identify and characterize proteins and genes that direct physiological maturation of heart muscle cells from stem cells. Heart muscle cells derived from stem cells typically lack electrical and mechanical properties of adult cardiomyocytes that are important for many research and clinical applications. The findings will constitute a conceptual advance since little is known about how physiological maturation is controlled, and will increase the value of stem cell-derived cardiomyocytes for research and medical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
hiPSC Modeling of Restrictive Cardiomyopathy for Drug Testing
-
批准号:10716393
-
项目类别:
-
资助金额:$57.24万
-
财政年份:2023
-
负责人:MARK MERCOLA
-
依托单位:
High throughput platform for simultaneous multiparametric assessment of cardiac physiology for heart failure drug development
-
批准号:10745000
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2023
-
负责人:MARK MERCOLA
-
依托单位:
Targeting the genotype to phenotype link in HCM as a therapeutic strategy
-
批准号:10355529
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2021
-
负责人:MARK MERCOLA
-
依托单位:
Targeting the genotype to phenotype link in HCM as a therapeutic strategy
-
批准号:10576285
-
项目类别:
-
资助金额:$58.33万
-
财政年份:2021
-
负责人:MARK MERCOLA
-
依托单位:
Kinetic Imaging Cytometer (KIC) for High Throughput Studies of Cellular Physiology
-
批准号:10175806
-
项目类别:
-
资助金额:$52.83万
-
财政年份:2021
-
负责人:MARK MERCOLA
-
依托单位:
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation
-
批准号:10671175
-
项目类别:
-
资助金额:$61.82万
-
财政年份:2019
-
负责人:MARK MERCOLA
-
依托单位:
Project 3 (Mercola)
-
批准号:10471340
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2019
-
负责人:MARK MERCOLA
-
依托单位:
Project 3 (Mercola)
-
批准号:10677717
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2019
-
负责人:MARK MERCOLA
-
依托单位:
Project 3 (Mercola)
-
批准号:10249149
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2019
-
负责人:MARK MERCOLA
-
依托单位:
Project 3 (Mercola)
-
批准号:10006342
-
项目类别:
-
资助金额:$51.4万
-
财政年份:2019
-
负责人:MARK MERCOLA
-
依托单位:
MicroRNA Control of Dilated Cardiomyopathy
-
批准号:9173372
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2016
-
负责人:MARK MERCOLA
-
依托单位:
MicroRNA Control of Dilated Cardiomyopathy
-
批准号:9278284
-
项目类别:
-
资助金额:$55.09万
-
财政年份:2016
-
负责人:MARK MERCOLA
-
依托单位:
Small Molecule NOTCH Inhibitors for the treatment of pulmonary hypertension
-
批准号:9462667
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2016
-
负责人:MARK MERCOLA
-
依托单位:
microRNAs and Integrative Control on Cardiopoiesis - CHANGE OF GRANTEE INSTITUTIO
-
批准号:8915242
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2014
-
负责人:MARK MERCOLA
-
依托单位:
microRNAs and Integrative Control on Cardiopoiesis
-
批准号:9061801
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2014
-
负责人:MARK MERCOLA
-
依托单位:
microRNAs and Integrative Control on Cardiopoiesis - CHANGE OF GRANTEE INSTITUTIO
-
批准号:8787935
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2014
-
负责人:MARK MERCOLA
-
依托单位:
Endothelial hiPSC-Cardiomyocyte Interactions Relevant to Model Disease and Aging
-
批准号:8851826
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2013
-
负责人:MARK MERCOLA
-
依托单位:
Endothelial hiPSC-Cardiomyocyte Interactions Relevant to Model Disease and Aging
-
批准号:8584116
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2013
-
负责人:MARK MERCOLA
-
依托单位:
CHEMICAL LIBRARY SCREENING
-
批准号:8378399
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2012
-
负责人:MARK MERCOLA
-
依托单位:
microRNAs and integrative control of cardiopoiesis
-
批准号:8276579
-
项目类别:
-
资助金额:$50.95万
-
财政年份:2012
-
负责人:MARK MERCOLA
-
依托单位:
海外基金